Condition
Lynch Syndrome I (Site-specific Colonic Cancer)
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 3 (1)
Trial Status
Recruiting2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06708429Recruiting
Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
NCT07450612Recruiting
Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection
NCT02497820Phase 3Not Yet RecruitingPrimary
Finding the Best Dose of Aspirin to Prevent Lynch Syndrome Cancers
Showing all 3 trials